Loading…
Medartis Holding AG agreed to acquire the remaining 53% stake in KeriMedical for CHF 99 million in cash, following FDA approval of the KeriMedical TOUCH prosthesis.
Medartis Holding AG acquired a strategic minority stake of 25% in KeriMedical for CHF 10 million, with exclusive distribution rights in selected markets and a partnership in product development.